WindMIL Therapeutics, Inc. — Form D
WindMIL Therapeutics, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2016-04-07. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-04-07
- Form: D
- Accession: 0001671352-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $10.0M
- Investors: 4
- Date of first sale: 2016-03-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-260852
Issuer
- Name: WindMIL Therapeutics, Inc.
- CIK: 0001671352
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 3675 MARKET STREET, PHILADELPHIA, PA, 19104
- Phone: 4105581906
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Brian Halak | Director | South San Francisco, CA |
| Brian Halak | Executive Officer | South San Francisco, CA |
| BRIAN DOVEY | Director | LEXINGTON, MA |
| Donald J Hayden, Jr. | Director | Philadelphia, PA |
| Donald J Hayden, Jr. | Executive Officer | Philadelphia, PA |
| Patrick J Fabbio | Executive Officer | Philadelphia, PA |
| Howard J Soule | Director | Philadelphia, PA |
| Daniel J O'Donnell | Director | Philadelphia, PA |
| Mark J McDade | Director | Philadelphia, PA |
| Anna J French | Director | Philadelphia, PA |
| Brian J Dovey | Director | Philadelphia, PA |
| Allan Fox | Director | Boston, MA |
| Howard Soule | Director | Baltimore, MD |
| Donald Hayden, Jr. | Director | Baltimore, MD |
Other filings by this issuer (2)
More